Internal Medicine, Endocrinology, Diabetes, & Metabolism · Philadelphia, PA
NPI
1467679738
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
9880 Bustleton Ave, Ste 220
Philadelphia, PA, 19115
Phone (215) 827-1500
Groups this clinician bills Medicare through
Medicare paid, 2024
$254K
4,218 services
Medicare patients, 2024
965
Average age 76
Drug cost, 2024
$8.3M
28,431 prescriptions
Company payments, 2025
$45K
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jane Mayrin was code 99214 (office e&m - established), 1,390 times for 770 patients. In total Jane Mayrin billed 4,218 services in 16 codes, and Medicare paid $254K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-04-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,390 | 770 | $93.51 | $130K |
| 99232 Hospital E&M - Subsequent | Facility | 1,255 | 123 | $63.28 | $79K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 742 | 485 | $13.28 | $9,856 |
| 96372 Injection Administration | Office | 383 | 199 | $10.97 | $4,201 |
| 95251 Test - Miscellaneous | Office | 206 | 101 | $27.55 | $5,675 |
| 99222 Hospital E&M - Initial | Facility | 65 | 64 | $107.83 | $7,009 |
| 99204 Office E&M - New | Office | 62 | 62 | $111.24 | $6,897 |
| 99223 Hospital E&M - Initial | Facility | 41 | 39 | $138.58 | $5,682 |
| 99213 Office E&M - Established | Office | 25 | 22 | $48.30 | $1,208 |
| 99211 Office E&M - Established | Office | 11 | 11 | $20.29 | $223 |
By year: 2022 $223K for 3,155 services; 2023 $229K for 3,226 services; 2024 $254K for 4,218 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jane Mayrin prescribed most often to Medicare patients was Metformin Hcl, with 1,987 prescriptions and refills. In total Jane Mayrin wrote 28,431 Medicare prescriptions that cost $8.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metformin Hcl Generic | 1,987 | 2,582 | 263 | $13K |
| Levothyroxine Sodium Generic | 1,588 | 2,198 | 216 | $11K |
| Trulicity Dulaglutide | 1,481 | 1,538 | 173 | $1.5M |
| Pioglitazone Hcl Generic | 1,280 | 1,774 | 174 | $13K |
| Atorvastatin Calcium Generic | 1,215 | 1,825 | 218 | $7,845 |
| Ozempic Semaglutide | 1,071 | 1,150 | 134 | $1.1M |
| Glimepiride Generic | 964 | 1,420 | 151 | $6,950 |
| Glipizide Generic | 959 | 1,307 | 129 | $8,074 |
| Farxiga Dapagliflozin Propanediol | 898 | 1,012 | 107 | $573K |
| Alendronate Sodium Generic | 896 | 1,096 | 124 | $4,280 |
| Rosuvastatin Calcium Generic | 832 | 1,072 | 117 | $7,319 |
| Vascepa Icosapent Ethyl | 765 | 833 | 88 | $292K |
| Jardiance Empagliflozin | 670 | 856 | 111 | $493K |
| Synthroid Levothyroxine Sodium | 651 | 744 | 70 | $34K |
| Metformin Hcl Er Metformin Hcl | 554 | 745 | 77 | $6,051 |
Brand drugs: 10,845 claims; generic drugs: 15,991 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jane Mayrin $45K ($45K in general payments such as food, travel and fees) from 29 companies. The largest payer was Novo Nordisk Inc with $26K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 40 | $26K |
| Lilly USA, LLC LLY | 35 | $18K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $232 |
| Amgen Inc. AMGN | 11 | $205 |
| Radius Health, Inc. | 6 | $192 |
| Almatica Pharma LLC | 8 | $152 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $142 |
| Astellas Pharma US Inc 4503.T | 4 | $135 |
| Amphastar Pharmaceuticals, Inc. AMPH | 6 | $120 |
| Medtronic, Inc. MDT | 5 | $114 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.